Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr;19(4):390-400.
doi: 10.1007/s12519-022-00677-4. Epub 2023 Feb 13.

A predictive model of response to metoprolol in children and adolescents with postural tachycardia syndrome

Affiliations

A predictive model of response to metoprolol in children and adolescents with postural tachycardia syndrome

Bo-Wen Xu et al. World J Pediatr. 2023 Apr.

Abstract

Background: The present work was designed to explore whether electrocardiogram (ECG) index-based models could predict the effectiveness of metoprolol therapy in pediatric patients with postural tachycardia syndrome (POTS).

Methods: This study consisted of a training set and an external validation set. Children and adolescents with POTS who were given metoprolol treatment were enrolled, and after follow-up, they were grouped into non-responders and responders depending on the efficacy of metoprolol. The difference in pre-treatment baseline ECG indicators was analyzed between the two groups in the training set. Binary logistic regression analysis was further conducted on the association between significantly different baseline variables and therapeutic efficacy. Nomogram models were established to predict therapeutic response to metoprolol. The receiver-operating characteristic curve (ROC), calibration, and internal validation were used to evaluate the prediction model. The predictive ability of the model was validated in the external validation set.

Results: Of the 95 enrolled patients, 65 responded to metoprolol treatment, and 30 failed to respond. In the responders, the maximum value of the P wave after correction (Pcmax), P wave dispersion (Pd), Pd after correction (Pcd), QT interval dispersion (QTd), QTd after correction (QTcd), maximum T-peak-to-T-end interval (Tpemax), and T-peak-to-T-end interval dispersion (Tped) were prolonged (all P < 0.01), and the P wave amplitude was increased (P < 0.05) compared with those of the non-responders. In contrast, the minimum value of the P wave duration after correction (Pcmin), the minimum value of the QT interval after correction (QTcmin), and the minimum T-peak-to-T-end interval (Tpemin) in the responders were shorter (P < 0.01, < 0.01 and < 0.01, respectively) than those in the non-responders. The above indicators were screened based on the clinical significance and multicollinearity analysis to construct a binary logistic regression. As a result, pre-treatment Pcmax, QTcmin, and Tped were identified as significantly associated factors that could be combined to provide an accurate prediction of the therapeutic response to metoprolol among the study subjects, yielding good discrimination [area under curve (AUC) = 0.970, 95% confidence interval (CI) 0.942-0.998] with a predictive sensitivity of 93.8%, specificity of 90.0%, good calibration, and corrected C-index of 0.961. In addition, the calibration curve and standard curve had a good fit. The accuracy of internal validation with bootstrap repeated sampling was 0.902. In contrast, the kappa value was 0.769, indicating satisfactory agreement between the predictive model and the results from the actual observations. In the external validation set, the AUC for the prediction model was 0.895, and the sensitivity and specificity were 90.9% and 95.0%, respectively.

Conclusions: A high-precision predictive model was successfully developed and externally validated. It had an excellent predictive value of the therapeutic effect of metoprolol on POTS among children and adolescents.

Keywords: Children; Electrocardiography; Metoprolol; Nomogram; Postural tachycardia syndrome; Predictor.

PubMed Disclaimer

Conflict of interest statement

DJB is the deputy chief editor for World Journal of Pediatrics. DJB is not involved in the journal’s review of, or decisions related to this manuscript.

Figures

Fig. 1
Fig. 1
Flowchart of the inclusion of participants in the study. POTS postural tachycardia syndrome
Fig. 2
Fig. 2
An ROC analysis of the nomogram for evaluating the effectiveness of metoprolol in POTS in children in the training set. The y-axis represents the sensitivity to predict the response to metoprolol; the x-axis represents the specificity to predict the response to metoprolol. The 45° reference line of the chart indicates that the sensitivity and the specificity are equal to 50%. The area under the curve was 0.970 with a 95% confidence interval of 0.942–0.998. ROC receiver-operating characteristic curve, POTS postural tachycardia syndrome, AUC area under the curve
Fig. 3
Fig. 3
Nomogram for predicting the efficacy of metoprolol in children with POTS in the training set. To estimate the response to metoprolol, the patient score for each axis is marked, a line perpendicular to the point axis is drawn, and the points for all variables are summed. Next, the sum is marked on the total point axis, and a line perpendicular to the probability axis is drawn. POTS postural tachycardia syndrome, Pcmax the maximum value of P wave duration in 12 leads of electrocardiogram after correction, ms millisecond, QTcmin the minimum value of QT interval in 12 leads of electrocardiogram after correction, Tped T-peak-to-T-end dispersion
Fig. 4
Fig. 4
Calibration of the nomogram for predicting the efficacy of metoprolol in children with POTS in the training set. The x-axis shows the predicted probability of metoprolol response, and the y-axis shows the observed probability of metoprolol response. The ideal line means that the predicted and actual probabilities of the model agree perfectly. The apparent line indicates the actual performance of the prediction model in the training set. The bias-corrected line indicates the performance of the prediction model in the training set after the correction of the over-fitting situation. The calibration curve and standard curve have a good fit. POTS postural tachycardia syndrome
Fig. 5
Fig. 5
An ROC analysis of the nomogram for evaluating the effectiveness of metoprolol in POTS in children in the external validation set. The y-axis represents the sensitivity to predict the response to metoprolol; the x-axis represents the specificity to predict the response to metoprolol. The 45° reference line of the chart indicates that the sensitivity and the specificity are equal. The AUC was 0.895, and the sensitivity and specificity were 90.9% and 95%, respectively. ROC receiver-operating characteristic curve, POTS postural tachycardia syndrome, AUC area under the curve
Fig. 6
Fig. 6
Calibration of the nomogram for predicting the efficacy of metoprolol in children with POTS in the external validation set. The x-axis shows the predicted probability of metoprolol response, and the y-axis shows the observed probability of metoprolol response. The ideal line means that the predicted and actual probabilities of the model agree perfectly. The apparent line indicates the actual performance of the prediction model in the validation set. The bias-corrected line indicates the performance of the prediction model in the validation set after the correction of the overfitting situation. The calibration curve and standard curve have a good fit. POTS postural tachycardia syndrome

Similar articles

Cited by

References

    1. Vernino S, Bourne KM, Stiles LE, Grubb BP, Fedorowski A, Stewart JM, et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting—part 1. Auton Neurosci. 2021;235:102828. doi: 10.1016/j.autneu.2021.102828. - DOI - PMC - PubMed
    1. Bryarly M, Phillips LT, Fu Q, Vernino S, Levine BD. Postural orthostatic tachycardia syndrome: JACC focus seminar. J Am Coll Cardiol. 2019;73:120–128. doi: 10.1016/j.jacc.2018.11.059. - DOI - PubMed
    1. Lin J, Han Z, Li X, Ochs T, Zhao J, Zhang X, et al. Risk factors for postural tachycardia syndrome in children and adolescents. PLoS One. 2014;9:e113625. doi: 10.1371/journal.pone.0113625. - DOI - PMC - PubMed
    1. Zadourian A, Doherty TA, Swiatkiewicz I, Taub PR. Postural orthostatic tachycardia syndrome: prevalence, pathophysiology, and management. Drugs. 2018;78:983–994. doi: 10.1007/s40265-018-0931-5. - DOI - PubMed
    1. Deng X, Zhang Y, Liao Y, Du J. Efficacy of beta-blockers on postural tachycardia syndrome in children and adolescents: a systematic review and meta-analysis. Front Pediatr. 2019;7:460. doi: 10.3389/fped.2019.00460. - DOI - PMC - PubMed